Table 1 Baseline characteristics of prostate urethral biopsy in patients with bladder cancer.
Characteristics | n | Prostatic urethral biopsy | P-value | |
|---|---|---|---|---|
(+) | (−) | |||
Age (years, \(\:\stackrel{-}{x}\pm\:s\)) | 68.15 ± 11.03 | 68.44 ± 9.53 | 0.809 | |
< 65 | 93 | 37 (29.1%) | 56 (33.3%) | 0.521 |
≥ 65 | 202 | 90 (70.9%) | 112 (66.7%) | |
Tumor size (cm) | 0.009 | |||
< 3 | 175 | 64 (50.4%) | 111 (66.1%) | |
≥ 3 | 120 | 63 (49.6%) | 57 (33.9%) | |
Multiplicity | < 0.001 | |||
Single | 86 | 17 (13.4%) | 69 (41.1%) | |
Multiple | 209 | 110 (86.6%) | 99 (58.9%) | |
Tumor location | < 0.001 | |||
Trigone/neck | 153 | 105 (82.7%) | 48 (28.6%) | |
others | 142 | 22 (17.3%) | 120 (71.4%) | |
Stage | < 0.001 | |||
pTa | 26 | 2 ( 1.6%) | 24 (14.3%) | |
pT1 | 199 | 88 (69.3%) | 111 (66.1%) | |
pT2-T4 | 70 | 37 (29.1%) | 33 (19.6%) | |
Grade | < 0.001 | |||
Low | 44 | 4 ( 3.1%) | 40 (23.8%) | |
High | 251 | 123 (96.9%) | 128 (76.2%) | |
Combined CIS | 0.875 | |||
Yes | 58 | 26 (20.5%) | 32 (19.0%) | |
No | 237 | 101 (79.5%) | 136 (81.0%) | |
recurrent carcinoma | < 0.001 | |||
Yes | 106 | 67 (52.8%) | 39 (23.2%) | |
No | 189 | 60 (47.2%) | 129 (76.8%) | |
